Related Experiment Videos
β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells
1Department of Medical Oncology, The First Hospital, China Medical University, Shenyang, China.
Objectives:
β-Elemene, a novel traditional Chinese medicine, has been shown to be effective against a wide range of tumours. In this study, the antitumour effect of β-elemene on human non-small-cell lung cancer (NSCLC) A549 cells and the mechanism involved have been investigated.
Methods:
Cell viability and apoptosis were measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry, respectively. Protein expression was assayed by Western blotting. Autophagy was evaluated under fluorescence microscopy and transmission electron microscopy.
Key Findings:
β-Elemene inhibited the viability of A549 cells in a dose-dependent manner. This suppression of cell viability was due to the induction of apoptosis. Further study showed that β-elemene inhibited the activity of the PI3K/Akt/mTOR/p70S6K1 signalling pathway, and at the same time it triggered a robust autophagy. The autophagy was characterized by the accumulation of punctate LC3 dots in the cytoplasm, morphological changes, and the increased levels of LC3-II as well as Atg5-Atg12 conjugated proteins. Inhibition of autophagy with chlorochine significantly enhanced the antitumour effect of β-elemene.
Conclusions:
Our data indicated that β-elemene inhibited the activity of the PI3K/Akt/mTOR/p70S6K1 signalling pathway in human NSCLC A549 cells, which resulted in apoptosis as well as protective autophagy. A combination of β-elemene with autophagy inhibitor might be an effective therapeutic option for advanced NSCLC.
Insights
β-Elemene, a traditional Chinese medicine, effectively inhibits non-small-cell lung cancer (NSCLC) A549 cell viability by inducing apoptosis and autophagy. Combining β-elemene with autophagy inhibitors may offer a novel therapeutic strategy for advanced NSCLC.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- β-Elemene is a traditional Chinese medicine with demonstrated anticancer properties.
- Non-small-cell lung cancer (NSCLC) remains a significant global health challenge requiring novel therapeutic approaches.
Purpose of the Study:
- To investigate the antitumour effects of β-elemene on human NSCLC A549 cells.
- To elucidate the underlying mechanisms, including apoptosis and autophagy induction, and the involvement of the PI3K/Akt/mTOR/p70S6K1 signaling pathway.
Main Methods:
- Cell viability assessed using MTT assay.
- Apoptosis measured by flow cytometry.
- Protein expression analyzed via Western blotting.
- Autophagy evaluated using fluorescence and transmission electron microscopy.
Main Results:
- β-Elemene dose-dependently inhibited A549 cell viability, inducing apoptosis.
- The compound suppressed the PI3K/Akt/mTOR/p70S6K1 signaling pathway.
- β-Elemene triggered significant autophagy, evidenced by LC3-II and Atg5-Atg12 accumulation.
- Autophagy inhibition with chloroquine enhanced β-elemene's antitumour efficacy.
Conclusions:
- β-Elemene induces apoptosis and protective autophagy in NSCLC A549 cells by inhibiting the PI3K/Akt/mTOR/p70S6K1 pathway.
- Combination therapy of β-elemene with autophagy inhibitors presents a promising strategy for treating advanced NSCLC.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway
Mitogens and the Cell Cycle